Ganetespib in first-line treatment of women with metastatic HER2 positive or triple negative breast cancer
Ganetespib in first-line treatment of women with metastatic HER2 positive or triple negative breast cancer
Regular physical activity reduces breast cancer risk irrespective of age
Radiotherapy after mastectomy benefit for breast cancer that has spread to just a few lymph nodes
ecancermedicalscience Editor's Choice for January 2014
Symptom management and quality of life in metastatic breast cancer
The impact of biological age on breast cancer
Aspirin trialled for breast cancer recurrence prevention
Drop in breast cancer mortality in developed countries varies
Radiation in the treatment of the axilla in neoadjuvant chemotherapy for breast cancer
Translational studies of CDK and PARP inhibitors
HER2 positive breast cancer treatment, past and future
Preventing metastases by tackling exosomes